Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that is mainly directed to the joints, affecting the synovial membrane, the cartilage and also the bone. This disease affects 1% to 2% of the world population and is associated with significant morbidity and increased mortality. RA experimental models have allowed a great deal of information to be translated to the corresponding human disease. This review summarizes some of the most relevant findings targeting immunomodulation in arthritis. Some general guidelines to choose an adequate experimental model and also our experience with arthritis are supplied.
WeyandCM. Immunopathologic aspects of rheumatoid arthritis: Who is the conductor and who plays the immunologic instrument?J Rheumatol Suppl2007; 79: 9–14.
2.
KlareskogLMalmströmVLundbergKPadyukovLAlfredssonL. Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin Immunol2011; 23: 92–98.
3.
ImbodenJB. The immunopathogenesis of rheumatoid arthritis. Annu Rev Pathol2009; 4: 417–434.
4.
YoungAKoduriG. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol2007; 21: 907–927.
5.
Van den BergWB. Lessons from animal models of arthritis over the past decade. Arthritis Res Ther2009; 11: 250–250.
6.
BolonBStolinaMKingC. Rodent preclinical models for developing novel antiarthritic molecules: Comparative biology and preferred methods for evaluating efficacy. J Biomed Biotechnol2011; 2011: 569068–569068.
7.
BlässSEngelJMBurmesterGR. The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences [article in German]. Z Rheumatol2001; 60: 1–16.
8.
LundbergKNijenhuisSVossenaarER. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther2005; 7: 458–467.
9.
HoPPLeeLYZhaoX. Autoimmunity against fibrinogen mediates inflammatory arthritis in mice. J Immunol2010; 184: 379–390.
10.
SokoloveJZhaoXChandraPERobinsonWH. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcγ receptor. Arthritis Rheum2011; 63: 53–62.
11.
UysalHBockermannRNandakumarKS. Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J Exp Med2009; 206: 449–462.
12.
PerriconeCCeccarelliFValesiniG. An overview on the genetic of rheumatoid arthritis: A never-ending story. Autoimmun Rev2011; 10: 599–608.
13.
RieckMArechigaAOnengut-GumuscuSGreenbaumCConcannonPBucknerJH. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol2007; 179: 4704–4710.
14.
SakaguchiNTakahashiTHataH. Altered thymic T-cell selection due to a mutation of the ZAP‐70 gene causes autoimmune arthritis in mice. Nature2003; 426: 454–460.
15.
MeronMKAmitalHShepshelovichD. Infectious aspects and the etiopathogenesis of rheumatoid arthritis. Clin Rev Allergy Immunol2010; 38: 287–291.
16.
BalandraudNMeynardJBAugerI. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: Accurate quantification using real-time polymerase chain reaction. Arthritis Rheum2003; 48: 1223–1228.
17.
SaalJGSteidleMEinseleH. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int1992; 12: 147–151.
YuHYangYHRajaiahR. Nicotine-induced differential modulation of autoimmune arthritis in the Lewis rat involves changes in interleukin-17 and anti-cyclic citrullinated peptide antibodies. Arthritis Rheum2011; 63: 981–991.
22.
van der HeijdenIMWilbrinkBTchetverikovI. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum2000; 43: 593–598.
23.
LeeEKKangSMPaikDJKimJMYounJ. Essential roles of Toll-like receptor-4 signaling in arthritis induced by type II collagen antibody and LPS. Int Immunol2005; 17: 325–333.
24.
MengLZhuWJiangC. Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats. Arthritis Res Ther2010; 12: R103–R103.
NotleyCAInglisJJAlzabinSMcCannFEMcNameeKEWilliamsRO. Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells. J Exp Med2008; 205: 2491–2497.
27.
CarvalheiroHMda SilvaJASouto-CarneiroMM. Potential roles for CD8(+) T cells in rheumatoid arthritis. Autoimmun Rev2013; 12: 401–409.
28.
GaffenSL. The role of interleukin-17 in the pathogenesis of rheumatoid arthritis. Curr Rheumatol Rep2009; 11: 365–370.
29.
LundySKSarkarSTesmerLAFoxDA. Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res Ther2007; 9: 202–202.
30.
SatoKSuematsuAOkamotoK. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med2006; 203: 2673–2682.
31.
DongWZhuP. Functional niche of inflamed synovium for Th17-cell expansion and activation in rheumatoid arthritis: Implication to clinical therapeutics. Autoimmun Rev2012; 11: 844–851.
32.
IsomakiPLuukkainenRSaarioRToivanenPPunnonenJ. Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium. Arthritis Rheum1996; 39: 386–395.
33.
MouraRAGracaLFonsecaJE. To B or not to B the conductor of rheumatoid arthritis orchestra. Clin Rev Allergy Immunol2012; 43: 281–291.
34.
BoissierMCAssierEBitonJDenysAFalgaroneGBessisN. Regulatory T cells (Treg) in rheumatoid arthritis. Joint Bone Spine2009; 76: 10–14.
35.
FontenotJDGavinMARudenskyAY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol2003; 4: 330–336.
36.
FreyOPetrowPKGajdaM. The role of regulatory T cells in antigen-induced arthritis: Aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res Ther2005; 7: 291–301.
37.
BettelliECarrierYGaoW. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature2006; 441: 235–238.
38.
LeeYKMukasaRHattonRDWeaverCT. Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol2009; 21: 274–280.
39.
EhrensteinMREvansJGSinghA. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med2004; 200: 277–285.
40.
HamelKMCaoYAshayeS. B cell depletion enhances T regulatory cell activity essential in the suppression of arthritis. J Immunol2011; 187: 4900–4906.
41.
McGovernJLNguyenDXNotleyCAMauriCIsenbergDAEhrensteinMR. Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy. Arthritis Rheum2012; 64: 3129–3138.
42.
UrryZChambersESXystrakisE. The role of 1α,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells. Eur J Immunol2012; 42: 2697–2708.
43.
StraussLWhitesideTLKnightsABergmannCKnuthAZippeliusA. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. J Immunol2007; 178: 320–329.
44.
KesselAAmmuriHPeriR. Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function. J Immunol2007; 179: 5571–5575.
45.
CaoTWenzelSEFaubionWAHarrimanGLiL. Enhanced suppressive function of regulatory T cells from patients with immune-mediated diseases following successful ex vivo expansion. Clin Immunol2010; 136: 329–337.
46.
XuWRoosADahaMRvan KootenC. Dendritic cell and macrophage subsets in the handling of dying cells. Immunobiology2006; 211: 567–575.
47.
MorelliAELarreginaATShufeskyWJ. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: Dependence on complement receptors and effect on cytokine production. Blood2003; 101: 611–620.
48.
StuartLMLucasMSimpsonCLambJSavillJLacy-HulbertA. Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J Immunol2002; 168: 1627–1635.
49.
VostersONèveJde WitDWillemsFGoldmanMVerhasseltV. Dendritic cells exposed to nacystelyn are refractory to maturation and promote the emergence of alloreactive regulatory T cells. Transplantation2003; 75: 383–389.
50.
Torres-AguilarHAguilar-RuizSRGonzález-PérezG. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. J Immunol2010; 184: 1765–1775.
51.
ZhaoYZhangADuHGuoSNingBYangS. Tolerogenic dendritic cells and rheumatoid arthritis: Current status and perspectives. Rheumatol Int2012; 32: 837–844.
52.
ZanettiMCastiglioniPSchoenbergerSGerloniM. The role of relB in regulating the adaptive immune response. Ann N Y Acad Sci2003; 987: 249–257.
KabalakGDobbersteinSBMatthiasT. Association of immunoglobulin-like transcript 6 deficiency with Sjögren’s syndrome. Arthritis Rheum2009; 60: 2923–2925.
55.
CriadoGSimelyteEInglisJJEssexDWilliamsRO. Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis. Arthritis Rheum2009; 60: 1342–1351.
56.
Marin-GallenSClemente-CasaresXPlanasR. Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes. Clin Exp Immunol2010; 160: 207–214.
57.
SteinmanRMTurleySMellmanIInabaK. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med2000; 191: 411–416.
58.
KushwahRWuJOliverJR. Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg. Eur J Immunol2010; 40: 1022–1035.
59.
HumbertJMHalaryF. Viral and non-viral methods to genetically modify dendritic cells. Curr Gene Ther2012; 12: 127–136.
60.
HenryEDesmetCJGarzéV. Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma. J Immunol2008; 181: 7230–7242.
61.
LiRZhengXPopovI. Gene silencing of IL-12 in dendritic cells inhibits autoimmune arthritis. J Transl Med2012; 10: 19–19.
62.
MisakiKMorinobuASaegusaJ. Histone deacetylase inhibition alters dendritic cells to assume a tolerogenic phenotype and ameliorates arthritis in SKG mice. Arthritis Res Ther2011; 13: R77–R77.
63.
StoopJNHarryRAVon DelwigAIsaacsJDRobinsonJHHilkensCM. Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses. Arthritis Rheum2010; 62: 3656–3665.
64.
ZhengXSuzukiMIchimTE. Treatment of autoimmune arthritis using RNA interference-modulated dendritic cells. J Immunol2010; 184: 6457–6464.
65.
KoHJChoMLLeeSY. CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population. J Autoimmun2010; 34: 111–120.
66.
BrownAJRitterCS. The vitamin D analog 1α,25-dihydroxy-2β-(3-hydroxypropyloxy) vitamin D(3) (eldecalcitol) is a potent regulator of calcium and phosphate metabolism. Calcif Tissue Int2011; 89: 372–378.
67.
DelucaHFCantornaMT. Vitamin D: Its role and uses in immunology. FASEB J2001; 15: 2579–2585.
68.
van EttenEMathieuC. Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. J Steroid Biochem Mol Biol2005; 97: 93–101.
69.
BoonstraABarratFJCrainCHeathVLSavelkoulHFO’GarraA. 1alpha,25-dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol2001; 167: 4974–4980.
70.
Staeva-VieiraTPFreedmanLP. 1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J Immunol2002; 168: 1181–1189.
71.
PennaGAmuchasteguiSLavernyGAdoriniL. Vitamin D receptor agonists in the treatment of autoimmune diseases: Selective targeting of myeloid but not plasmacytoid dendritic cells. J Bone Miner Res2007; 22: 69–73.
72.
ChambersESHawrylowiczCM. The impact of vitamin D on regulatory T cells. Curr Allergy Asthma Rep2011; 11: 29–36.
73.
SouberbielleJCBodyJJLappeJM. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer. Recommendations for clinical practice. Autoimmun Rev2010; 9: 709–715.
74.
Agmon-LevinNTheodorESegalRMShoenfeldY. Vitamin D in systemic and organ-specific autoimmune diseases. Clinic Rev Allerg Immunol2012; 45: 265–266.
ShapiraYAgmon-LevinNShoenfeldY. Mycobacterium tuberculosis, autoimmunity, and vitamin D. Clin Rev Allerg Immunol2010; 38: 169–177.
77.
OrbachHZandman-GoddardGAmitalH. Novel biomarkers in autoimmune diseases. Prolactin, ferritin, vitamin D and TPA levels in autoimmune diseases. Ann NY Acad Sci2007; 1109: 385–400.
78.
ShoenfeldNAmitalHShoenfeldY. The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nature Clin Pract Rheumatol2009; 5: 99–105.
79.
AmitalHSzekaneczZSzücsG. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: Is it time to routinely supplement patients with SLE with vitamin D?Ann Rheum Dis2010; 69: 1155–1157.
80.
HajasASandorJCasathyL. Vitamin D insufficiency in a large MCTD population. Autoimmun Rev2011; 10: 317–324.
81.
CantornaMTHayesCEDelucaHF. 1,25-dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr1998; 128: 68–72.
82.
GregoriSGiarratanaNSmiroldoSUskokovicMAdoriniL. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes2002; 51: 1367–1374.
83.
PedersenAEGadMWalterMRClaessonMH. Induction of regulatory dendritic cells by dexamethasone and 1alpha,25-dihydroxyvitamin D(3). Immunol Lett2004; 91: 63–69.
84.
ArnsonYAmitalHShoenfeldY. Vitamin D and autoimmunity: New etiological and therapeutical considerations. Ann Rheum Dis2007; 66: 1137–1142.
85.
OrenYShapiraYAgmon-LevinN. Vitamin D insufficiency in a sunny environment: A demographic and seasonal analysis. Isr Med Assoc J2010; 12: 751–756.
86.
AnticoATampoiaMTozzoliRBizzaroN. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev2012; 12: 127–136.
87.
OkadaHKuhnCFeilletHBachJF. The ‘hygiene hypothesis’ for autoimmune and allergic diseases: An update. Clin Exp Immunol2010; 160: 1–9.
88.
KivitySAgmon-LevinNBlankMShoenfeldY. Infections and autoimmunity—friends or foes?Trends Immunol2009; 30: 409–414.
89.
RookGA. The hygiene hypothesis and the increasing prevalence of chronic inflammatory disorders. Trans R Soc Trop Med Hyg2007; 101: 1072–1074.
90.
ShorDBShoenfeldY. Will worms cure rheumatoid arthritis?Nature Rev Rheumatol2013; 9: 138–140.
91.
McInnesIBLeungBPHarnettMGracieJALiewFYHarnettW. A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J Immunol2003; 171: 2127–2133.
92.
HarnettMMKeanDEBoitelleA. The phosphorycholine moiety of the filarial nematode immunomodulator ES-62 is responsible for its anti-inflammatory action in arthritis. Ann Rheum Dis2008; 67: 518–523.
93.
GrundtmanCKreutmayerSBAlmanzarGWickMCWickG. Heat shock protein 60 and immune inflammatory responses in atherosclerosis. Arterioscler Thromb Vasc Biol2011; 31: 960–968.
94.
JonesDBCoulsonAFDuffGW. Sequence homologies between hsp60 and autoantigens. Immunol Today1993; 14: 115–118.
95.
van EdenWWickGAlbaniSCohenI. Stress, heat shock proteins, and autoimmunity: How immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases. Ann N Y Acad Sci2007; 1113: 217–237.
ShererYGerliRBocciEB. Heat-shock protein 65 autoantibodies are differently associated with early atherosclerosis in rheumatoid arthritis and in healthy subjects. Ann N Y Acad Sci2007; 1108: 408–413.
98.
CoelhoVFariaAM. HSP60: Issues and insights on its therapeutic use as an immunoregulatory agent. Front Immunol2011; 2: 97–97.
99.
HuangMNYuHMoudgilKD. The involvement of heat-shock proteins in the pathogenesis of autoimmune arthritis: A critical appraisal. Semin Arthritis Rheum2010; 40: 164–175.
100.
AndertonSMvan der ZeeRPrakkenBNoordzijAvan EdenW. Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis. J Exp Med1995; 181: 943–952.
101.
PrakkenBJWendlingUvan der ZeeRRuttenVPKuisWvan EdenW. Induction of IL-10 and inhibition of experimental arthritis are specific features of microbial heat shock proteins that are absent for other evolutionarily conserved immunodominant proteins. J Immunol2001; 167: 4147–4153.
102.
NishikawaHKatoTTawaraI. Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells. J Exp Med2005; 201: 681–686.
103.
OhueRHashimotoKNakamotoM. Bacterial heat shock protein 60, GroEL, can induce the conversion of naïve T cells into a CD4 CD25(+) Foxp3-expressing phenotype. Immunol2001; 167: 4147–4153.
104.
Zonneveld-HuijssoonERoordSTDe JagerW. Bystander suppression of experimental arthritis by nasal administration of a heat shock protein peptide. Ann Rheum Dis2011; 70: 2199–2206.
105.
Dominguez MdelCLorenzoNBarberaA. An altered peptide ligand corresponding to a novel epitope from heat-shock protein 60 induces regulatory T cells and suppresses pathogenic response in an animal model of adjuvant-induced arthritis. Autoimmunity2011; 44: 471–482.
106.
Santos-JuniorRRSartoriADe FrancoM. Immunomodulation and protection induced by DNA-hsp65 vaccination in an animal model of arthritis. Hum Gene Ther2005; 6: 1338–1345.
107.
BurkartVGermaschewskiLSchlootNCBellmannKKolbH. Deficient heat shock protein 70 response to stress in leukocytes at onset of type 1 diabetes. Biochem Biophys Res Commun2008; 369: 421–425.
108.
WietenLvan der ZeeRSpieringR. A novel heat-shock protein coinducer boosts stress protein Hsp70 to activate T cell regulation of inflammation in autoimmune arthritis. Arthritis Rheum2010; 62: 1026–1035.
109.
Zanin-ZhorovACahalonLTalGMargalitRLiderOCohenIR. Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J Clin Invest2006; 116: 2022–2032.
110.
FrisendaSPerriconeCValesiniG. Cartilage as a target of autoimmunity: A thin layer. Autoimmun Rev2013; 12: 591–598.
111.
HuYChengWCaiWYueYLiJZhangP. Advances in research on animal models of rheumatoid arthritis. Clin Rheumatol2013; 32: 161–165.
112.
EylesJLHickeyMJNormanMU. A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis. Blood2008; 112: 5193–5201.
113.
Abdollahi-RoodsazSJoostenLARoelofsMF. Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum2007; 56: 2957–2967.
114.
KiddBAHoPPSharpeO. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res Ther2008; 10: R119–R119.
115.
JoostenLAAbdollahi-RoodsazSHeuvelmans-JacobsM. T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: Crucial role of both interleukin-1beta and interleukin-17. Arthritis Rheum2008; 58: 98–108.
116.
PerrucheSSaasPChenW. Apoptotic cell-mediated suppression of streptococcal cell wall-induced arthritis is associated with alteration of macrophage function and local regulatory T-cell increase: A potential cell-based therapy?Arthritis Res Ther2009; 11: R104–R104.
117.
SunXLiuYHLvZY. rSj16, a recombinant protein of Schistosoma japonicum-derived molecule, reduces severity of the complete Freund’s adjuvant-induced adjuvant arthritis in rats’ model. Parasite Immunol2010; 32: 739–748.
118.
ChujoSOkamotoSSunaharaR. Cigarette smoke condensate extracts augment collagen-induced arthritis in mice. Int Immunopharmacol2010; 10: 1194–1199.
119.
TelekesAResetarABalintG. Fermented wheat germ extract (avemar) inhibits adjuvant arthritis. Ann N Y Acad Sci2007; 1110: 348–361.
120.
WilliamsRO. Collagen-induced arthritis in mice. Methods Mol Med2007; 136: 191–199.
121.
HolmdahlRLorentzenJCLuS. Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol Rev2001; 184: 184–202.
122.
LeeTPChiangBL. Sex differences in spontaneous versus induced animal models of autoimmunity. Autoimmun Rev2011; 11: 422–429.
123.
GlantTTMikeczK. Proteoglycan aggrecan-induced arthritis: A murine autoimmune model of rheumatoid arthritis. Methods Mol Med2004; 102: 313–338.
